Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Blocking the KATP channel may help treat migraines.

Promising cancer treatments were found, but the manufacturer closed.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Tridax procumbens may help treat diabetes.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Nerves and chemicals in the body can affect hair growth and loss.

Sex hormones affect brain injury differently in males and females.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

ATP-sensitive potassium channels play a role in chloroquine-induced itch in mice.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Trazodone might help reverse post finasteride syndrome.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.